Logo image of CENX

CENTURY ALUMINUM COMPANY (CENX) Stock Fundamental Analysis

NASDAQ:CENX - Nasdaq - US1564311082 - Common Stock - Currency: USD

21.41  +0.35 (+1.66%)

Fundamental Rating

4

Overall CENX gets a fundamental rating of 4 out of 10. We evaluated CENX against 157 industry peers in the Metals & Mining industry. CENX has a medium profitability rating, but doesn't score so well on its financial health evaluation. CENX has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

CENX had positive earnings in the past year.
In the past year CENX had a positive cash flow from operations.
CENX had negative earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: CENX reported negative operating cash flow in multiple years.
CENX Yearly Net Income VS EBIT VS OCF VS FCFCENX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M -200M 300M

1.2 Ratios

The Return On Assets of CENX (5.80%) is better than 78.98% of its industry peers.
CENX's Return On Equity of 15.60% is amongst the best of the industry. CENX outperforms 87.26% of its industry peers.
CENX's Return On Invested Capital of 8.64% is fine compared to the rest of the industry. CENX outperforms 79.62% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CENX is significantly below the industry average of 12.07%.
The last Return On Invested Capital (8.64%) for CENX is above the 3 year average (3.18%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 5.8%
ROE 15.6%
ROIC 8.64%
ROA(3y)4.38%
ROA(5y)-1.26%
ROE(3y)10.09%
ROE(5y)-6.4%
ROIC(3y)3.18%
ROIC(5y)N/A
CENX Yearly ROA, ROE, ROICCENX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

1.3 Margins

The Profit Margin of CENX (4.79%) is better than 70.70% of its industry peers.
Looking at the Operating Margin, with a value of 7.00%, CENX is in the better half of the industry, outperforming 60.51% of the companies in the same industry.
CENX's Operating Margin has improved in the last couple of years.
The Gross Margin of CENX (9.69%) is comparable to the rest of the industry.
CENX's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 7%
PM (TTM) 4.79%
GM 9.69%
OM growth 3Y20%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y12.87%
GM growth 5YN/A
CENX Yearly Profit, Operating, Gross MarginsCENX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10

More info and screens

1

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CENX is destroying value.
CENX has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, CENX has more shares outstanding
The debt/assets ratio for CENX is higher compared to a year ago.
CENX Yearly Shares OutstandingCENX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
CENX Yearly Total Debt VS Total AssetsCENX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

CENX has an Altman-Z score of 1.51. This is a bad value and indicates that CENX is not financially healthy and even has some risk of bankruptcy.
CENX has a worse Altman-Z score (1.51) than 69.43% of its industry peers.
CENX has a Debt/Equity ratio of 0.64. This is a neutral value indicating CENX is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.64, CENX is not doing good in the industry: 81.53% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.64
Debt/FCF N/A
Altman-Z 1.51
ROIC/WACC0.91
WACC9.52%
CENX Yearly LT Debt VS Equity VS FCFCENX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

CENX has a Current Ratio of 1.84. This is a normal value and indicates that CENX is financially healthy and should not expect problems in meeting its short term obligations.
CENX has a Current ratio of 1.84. This is in the lower half of the industry: CENX underperforms 62.42% of its industry peers.
CENX has a Quick Ratio of 1.84. This is a bad value and indicates that CENX is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.63, CENX is not doing good in the industry: 83.44% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.84
Quick Ratio 0.63
CENX Yearly Current Assets VS Current LiabilitesCENX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 282.05% over the past year.
The Revenue has grown by 11.41% in the past year. This is quite good.
Measured over the past years, CENX shows a small growth in Revenue. The Revenue has been growing by 3.87% on average per year.
EPS 1Y (TTM)282.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%1300%
Revenue 1Y (TTM)11.41%
Revenue growth 3Y0.12%
Revenue growth 5Y3.87%
Sales Q2Q%29.5%

3.2 Future

The Earnings Per Share is expected to grow by 62.41% on average over the next years. This is a very strong growth
CENX is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 10.44% yearly.
EPS Next Y127.18%
EPS Next 2Y29.91%
EPS Next 3Y62.41%
EPS Next 5YN/A
Revenue Next Year14.86%
Revenue Next 2Y8.11%
Revenue Next 3Y10.44%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CENX Yearly Revenue VS EstimatesCENX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B 2B 2.5B
CENX Yearly EPS VS EstimatesCENX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 4

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

CENX is valuated correctly with a Price/Earnings ratio of 14.37.
86.62% of the companies in the same industry are more expensive than CENX, based on the Price/Earnings ratio.
CENX's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.03.
CENX is valuated reasonably with a Price/Forward Earnings ratio of 11.53.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CENX indicates a somewhat cheap valuation: CENX is cheaper than 75.16% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 36.28, CENX is valued rather cheaply.
Industry RankSector Rank
PE 14.37
Fwd PE 11.53
CENX Price Earnings VS Forward Price EarningsCENX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CENX is valued a bit cheaper than the industry average as 71.34% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 9.65
CENX Per share dataCENX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20 25

4.3 Compensation for Growth

CENX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CENX has a very decent profitability rating, which may justify a higher PE ratio.
CENX's earnings are expected to grow with 62.41% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.11
PEG (5Y)N/A
EPS Next 2Y29.91%
EPS Next 3Y62.41%

More info and screens

0

5. Dividend

5.1 Amount

CENX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CENTURY ALUMINUM COMPANY

NASDAQ:CENX (8/6/2025, 10:56:08 AM)

21.41

+0.35 (+1.66%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)05-07 2025-05-07/amc
Earnings (Next)08-07 2025-08-07/amc
Inst Owners58.85%
Inst Owner Change-0.24%
Ins Owners0.95%
Ins Owner Change0.06%
Market Cap2.00B
Analysts84.44
Price Target22.95 (7.19%)
Short Float %12.76%
Short Ratio4.3
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-14.23%
Min EPS beat(2)-36.41%
Max EPS beat(2)7.95%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)13.83%
Min Revenue beat(2)7.6%
Max Revenue beat(2)20.06%
Revenue beat(4)3
Avg Revenue beat(4)9.29%
Min Revenue beat(4)-1.34%
Max Revenue beat(4)20.06%
Revenue beat(8)6
Avg Revenue beat(8)7.05%
Revenue beat(12)7
Avg Revenue beat(12)4.28%
Revenue beat(16)8
Avg Revenue beat(16)2.39%
PT rev (1m)-0.74%
PT rev (3m)-3.57%
EPS NQ rev (1m)-38.89%
EPS NQ rev (3m)-69.72%
EPS NY rev (1m)0%
EPS NY rev (3m)-21.35%
Revenue NQ rev (1m)3.36%
Revenue NQ rev (3m)-0.5%
Revenue NY rev (1m)3.57%
Revenue NY rev (3m)3.96%
Valuation
Industry RankSector Rank
PE 14.37
Fwd PE 11.53
P/S 0.84
P/FCF N/A
P/OCF 31.96
P/B 2.75
P/tB 2.75
EV/EBITDA 9.65
EPS(TTM)1.49
EY6.96%
EPS(NY)1.86
Fwd EY8.67%
FCF(TTM)-0.12
FCFYN/A
OCF(TTM)0.67
OCFY3.13%
SpS25.35
BVpS7.78
TBVpS7.78
PEG (NY)0.11
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 5.8%
ROE 15.6%
ROCE 10.99%
ROIC 8.64%
ROICexc 8.9%
ROICexgc 8.9%
OM 7%
PM (TTM) 4.79%
GM 9.69%
FCFM N/A
ROA(3y)4.38%
ROA(5y)-1.26%
ROE(3y)10.09%
ROE(5y)-6.4%
ROIC(3y)3.18%
ROIC(5y)N/A
ROICexc(3y)3.31%
ROICexc(5y)N/A
ROICexgc(3y)3.31%
ROICexgc(5y)N/A
ROCE(3y)4.05%
ROCE(5y)N/A
ROICexcg growth 3Y6.18%
ROICexcg growth 5YN/A
ROICexc growth 3Y6.18%
ROICexc growth 5YN/A
OM growth 3Y20%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y12.87%
GM growth 5YN/A
F-Score6
Asset Turnover1.21
Health
Industry RankSector Rank
Debt/Equity 0.64
Debt/FCF N/A
Debt/EBITDA 1.86
Cap/Depr 89.35%
Cap/Sales 3.12%
Interest Coverage 4.36
Cash Conversion 25.18%
Profit Quality N/A
Current Ratio 1.84
Quick Ratio 0.63
Altman-Z 1.51
F-Score6
WACC9.52%
ROIC/WACC0.91
Cap/Depr(3y)115.12%
Cap/Depr(5y)92.4%
Cap/Sales(3y)3.72%
Cap/Sales(5y)3.15%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)282.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%1300%
EPS Next Y127.18%
EPS Next 2Y29.91%
EPS Next 3Y62.41%
EPS Next 5YN/A
Revenue 1Y (TTM)11.41%
Revenue growth 3Y0.12%
Revenue growth 5Y3.87%
Sales Q2Q%29.5%
Revenue Next Year14.86%
Revenue Next 2Y8.11%
Revenue Next 3Y10.44%
Revenue Next 5YN/A
EBIT growth 1Y2805.26%
EBIT growth 3Y20.15%
EBIT growth 5YN/A
EBIT Next Year219.85%
EBIT Next 3Y66.3%
EBIT Next 5YN/A
FCF growth 1Y86.91%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y634.19%
OCF growth 3YN/A
OCF growth 5YN/A